Clinical trials
Phase 2/3 Respiratory Distress Syndrome trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2020 | 3 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Terminated | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| APR Applied Pharma Research s.a. | 2 |
| NICHD Neonatal Research Network | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| NeuroBo Pharmaceuticals Inc. | 1 |
| Regeneron Pharmaceuticals | 1 |
| The University of Texas Medical Branch, Galveston | 1 |
| University of Alabama at Birmingham | 1 |
| University of Texas Southwestern Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Respiratory Distress Syndrome | 9 |
| Acute Lung Injury | 4 |
| COVID-19 | 3 |
| Bronchopulmonary Dysplasia | 2 |
| Coronavirus Infections | 2 |
| Premature Birth | 2 |
| Dyspnea | 1 |
| Infections | 1 |
| Pneumonia | 1 |
| Pneumonia, Ventilator-Associated | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.